Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant nagase aalbuminemic rats
โ Scribed by Eun J. Kim; Myung G. Lee
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 153 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.333
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The pharmacokinetic and pharmacodynamic parameters of torasemide were compared after intravenous administration at a dose of 2 mg/kg to diabetic rats induced by alloxan (DMIA) or streptozotocin (DMIS), and their respective control rats. It was reported that torasemide was mainly metabolized via CYP2
Gender differences in pharmacokinetics and pharmacodynamics of azosemide were evaluated after intravenous, 10 mg kg -1 , and oral, 10 mg kg -1 , administration to male and female rats. After intravenous administration to male rats, the percentages of intravenous dose of azosemide recovered from enti
## Abstract It has been reported that plasma albumin concentrations were significantly lower in cancer patients than those in the healthy volunteers, and the expression and mRNA level of hepatic microsomal cytochrome P450 (CYP) 1A2 increased in mutant Nagase analbuminemic rats (NARs). After intrave